Nature Biotechnology
22, 1059 (2004)
Published online: 27 August 2004; | doi:10.1038/nbt0904-1059
As products enter clinic...scientists shown the door.Mark Ratner
Cambridge, Massachusetts
Companies are left with fewer resources to do early stage research as their focus shifts when their products enter clinical trials
|
